PCSK9 and hydrops fetalis: Collectively, these studies propose that, beyond its lipid-modulating role, PCSK9 may influence HF progression by participating in myocardial cell death patterns and abnormal activation of cardiac fibroblasts, leading to ventricular remodeling and, consequently, direct involvement in HF progression.